Myths vs. Facts: Getting Imbruvica (ibrutinib) Covered by Humana in New Jersey
Answer Box
Getting Imbruvica (ibrutinib) covered by Humana in New Jersey requires prior authorization and often step therapy with preferred BTK inhibitors first. Most plans place Imbruvica as non-preferred (Tier 4) while favoring acalabrutinib or zanubrutinib. If denied, appeal internally within 65 days, then escalate to New Jersey's